Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Quantification of smoking-induced occupancy of beta2-nicotinic acetylcholine receptors: estimation of nondisplaceable binding.

Esterlis I, Cosgrove KP, Batis JC, Bois F, Stiklus SM, Perkins E, Seibyl JP, Carson RE, Staley JK.

J Nucl Med. 2010 Aug;51(8):1226-33. doi: 10.2967/jnumed.109.072447. Epub 2010 Jul 21.

2.

Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited.

Cunningham VJ, Rabiner EA, Slifstein M, Laruelle M, Gunn RN.

J Cereb Blood Flow Metab. 2010 Jan;30(1):46-50. doi: 10.1038/jcbfm.2009.190. Epub 2009 Sep 9.

3.

Smoking cessation: How compelling is the evidence? A review.

Tønnesen P.

Health Policy. 2009 Jul;91 Suppl 1:S15-25. doi: 10.1016/S0168-8510(09)70004-1.

PMID:
19735853
4.

A pilot study of nicotine delivery to smokers from a metered-dose inhaler.

Caldwell B, Dickson S, Burgess C, Siebers R, Mala S, Parkes A, Crane J.

Nicotine Tob Res. 2009 Apr;11(4):342-7. doi: 10.1093/ntr/ntp027. Epub 2009 Apr 3.

PMID:
19346511
5.

Cardiovascular effect of bans on smoking in public places.

Meyers DG, Neuberger JS.

Am J Cardiol. 2008 Nov 15;102(10):1421-4. doi: 10.1016/j.amjcard.2008.06.065. Epub 2008 Sep 11. No abstract available.

PMID:
18993167
6.

Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette.

Brody AL, Mandelkern MA, Costello MR, Abrams AL, Scheibal D, Farahi J, London ED, Olmstead RE, Rose JE, Mukhin AG.

Int J Neuropsychopharmacol. 2009 Apr;12(3):305-16. doi: 10.1017/S146114570800922X. Epub 2008 Aug 18.

7.

Comparison of craving and withdrawal among four combination nicotine treatments.

Schneider NG, Cortner C, Gould JL, Koury MA, Olmstead RE.

Hum Psychopharmacol. 2008 Aug;23(6):513-7. doi: 10.1002/hup.947.

PMID:
18438964
8.

Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE.

J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9. Epub 2007 May 9. Review.

PMID:
17519979
9.

Decomposing the value of cigarettes using experimental auctions.

Monchuk DC, Rousu MC, Shogren JF, Nonnemaker J, Kosa KM.

Nicotine Tob Res. 2007 Jan;9(1):93-9.

PMID:
17365740
10.

Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers.

Staley JK, Krishnan-Sarin S, Cosgrove KP, Krantzler E, Frohlich E, Perry E, Dubin JA, Estok K, Brenner E, Baldwin RM, Tamagnan GD, Seibyl JP, Jatlow P, Picciotto MR, London ED, O'Malley S, van Dyck CH.

J Neurosci. 2006 Aug 23;26(34):8707-14.

11.

Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors.

Brody AL, Mandelkern MA, London ED, Olmstead RE, Farahi J, Scheibal D, Jou J, Allen V, Tiongson E, Chefer SI, Koren AO, Mukhin AG.

Arch Gen Psychiatry. 2006 Aug;63(8):907-15.

12.

Is there a common molecular pathway for addiction?

Nestler EJ.

Nat Neurosci. 2005 Nov;8(11):1445-9. Review.

PMID:
16251986
13.

123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibility.

Staley JK, van Dyck CH, Weinzimmer D, Brenner E, Baldwin RM, Tamagnan GD, Riccardi P, Mitsis E, Seibyl JP.

J Nucl Med. 2005 Sep;46(9):1466-72.

14.

Comparison of three nicotine treatments: initial reactions and preferences with guided use.

Schneider NG, Terrace S, Koury MA, Patel S, Vaghaiwalla B, Pendergrass R, Olmstead RE, Cortner C.

Psychopharmacology (Berl). 2005 Nov;182(4):545-50. Epub 2005 Oct 19.

PMID:
16133134
15.

Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors.

Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP, Evrard A, Cazala P, Cormier A, Mameli-Engvall M, Dufour N, Cloëz-Tayarani I, Bemelmans AP, Mallet J, Gardier AM, David V, Faure P, Granon S, Changeux JP.

Nature. 2005 Jul 7;436(7047):103-7.

PMID:
16001069
16.

Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers.

Sofuoglu M, Mouratidis M, Yoo S, Culligan K, Kosten T.

Psychopharmacology (Berl). 2005 Sep;181(3):504-10. Epub 2005 Oct 12.

PMID:
15983800
17.

Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments.

Rose JE, Behm FM.

Nicotine Tob Res. 2004 Jun;6(3):523-32.

PMID:
15203786
18.

Nicotine amplifies reward-related dopamine signals in striatum.

Rice ME, Cragg SJ.

Nat Neurosci. 2004 Jun;7(6):583-4. Epub 2004 May 16.

PMID:
15146188
19.

Frequency-dependent modulation of dopamine release by nicotine.

Zhang H, Sulzer D.

Nat Neurosci. 2004 Jun;7(6):581-2. Epub 2004 May 16.

PMID:
15146187
20.

Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas.

Mansvelder HD, Keath JR, McGehee DS.

Neuron. 2002 Mar 14;33(6):905-19.

Supplemental Content

Support Center